Calheiros, J.; Raimundo, L.; Morais, J.; Matos, A.C.; Minuzzo, S.A.; Indraccolo, S.; Sousa, E.; Silva, M.C.d.; Saraiva, L.
Antitumor Activity of the Xanthonoside XGAc in Triple-Negative Breast, Ovarian and Pancreatic Cancer by Inhibiting DNA Repair. Cancers 2023, 15, 5718.
https://doi.org/10.3390/cancers15245718
AMA Style
Calheiros J, Raimundo L, Morais J, Matos AC, Minuzzo SA, Indraccolo S, Sousa E, Silva MCd, Saraiva L.
Antitumor Activity of the Xanthonoside XGAc in Triple-Negative Breast, Ovarian and Pancreatic Cancer by Inhibiting DNA Repair. Cancers. 2023; 15(24):5718.
https://doi.org/10.3390/cancers15245718
Chicago/Turabian Style
Calheiros, Juliana, Liliana Raimundo, João Morais, Ana Catarina Matos, Sonia Anna Minuzzo, Stefano Indraccolo, Emília Sousa, Marta Correia da Silva, and Lucília Saraiva.
2023. "Antitumor Activity of the Xanthonoside XGAc in Triple-Negative Breast, Ovarian and Pancreatic Cancer by Inhibiting DNA Repair" Cancers 15, no. 24: 5718.
https://doi.org/10.3390/cancers15245718
APA Style
Calheiros, J., Raimundo, L., Morais, J., Matos, A. C., Minuzzo, S. A., Indraccolo, S., Sousa, E., Silva, M. C. d., & Saraiva, L.
(2023). Antitumor Activity of the Xanthonoside XGAc in Triple-Negative Breast, Ovarian and Pancreatic Cancer by Inhibiting DNA Repair. Cancers, 15(24), 5718.
https://doi.org/10.3390/cancers15245718
